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Introduction: Space radiation research has progressed
rapidly in recent years, but there remain large uncertain-
ties in predicting and extrapolating biological responses
to humans. Exposure to cosmic radiation and Solar Par-
ticle Events (SPEs) may pose a critical health risk to fu-
ture spaceflight crews and can have a serious impact to
all biomedical aspects of space exploration. The rela-
tively minimal shielding of the cancelled 1960’s Manned
Orbiting Laboratory (MOL) program’s space vehicle and
the high inclination polar orbits would have left the crew
susceptible to high exposures of cosmic radiation and
high dose-rate SPEs that are mostly unpredictable in fre-
quency and intensity.
Methods: In this study, we have modeled the nominal
and off-nominal radiation environment that a MOL-like
spacecraft vehicle would be exposed to during a 30-day
mission using high performance, multi-core computers.
Results: Projected doses from a historically large SPE
(e.g. the August 1972 solar event) have been analyzed
in the context of theMOL orbit profile, providing an oppor-
tunity to study its impact to crew health and subsequent
contingencies
Discussion: It is reasonable to presume that future com-
mercial, government, and military spaceflight missions
in low-Earth orbit (LEO) will have vehicles with similar
shielding and orbital profiles. Studying the impact of cos-
mic radiation to the mission’s operational integrity and
the health of MOL crewmembers provides an excellent
surrogate and case-study for future commercial and mil-
itary spaceflight missions.
Introduction
The Manned Orbiting Laboratory (MOL) program was
conceived in 1963 to define and demonstrate the per-
formance capabilities of humans in the novel environ-
ment of spaceflight and initially included many techno-
logical, observational, and biomedical investigations to
establish appropriate benchmarks5 (e.g. Figure 1). Sub-
sequently, in 1965, MOL was recast as a secret re-
connaissance platform to place two military astronauts
and an advanced camera system into low earth orbit
for 30 days. The new mission was to demonstrate the
military value of men in space through their ability to
acquire high-resolution photography of America’s Cold
War adversaries efficiently and effectively. The program
would have provided significant, reproducible and well-
documented physiological and psychological stressors
to its pilots permitting detailed evaluation of the effects
of extended spaceflight. However, the program was can-
celled in 1969 when unmanned satellites were already
providing comparable data at less expense.
FIG. 1: MOLvehicle. Artist’s depiction of the proposed MOL
vehicle platform (Douglas Aircraft Co., 1967).
The MOL program saw the initiation and development
of novel approaches and made lasting contributions in
the areas of in-flight radiation assessment, nutritional
and hygienic support, planning of workloads and rest pe-
riods with a minimum of real-time assistance from Earth,
and meaningful exercise to counter the effects of ex-
tended and uninterrupted weightlessness. These con-
tributions improved the success of operations of NASA’s
Apollo, Skylab, and Space Shuttle programs and con-
tinue to be utilized today aboard the International Space
Station (ISS).
The radiation environment of the MOL flights has
prompted specific curiosity given its unprecedented na-
ture for manned spaceflight. Except for small amounts
of radioisotopes used in manned space missions for in-
strument calibration and research, the vast majority of
crew exposures are due to the complex radiation envi-
ronment in which they must travel and live. The space
radiation environment in low-Earth orbit (LEO) can be di-
vided into three separate sources of ionizing radiation:
solar wind, consisting of mostly low energy protons and
electrons; heavy-charged particles found in the Galactic
Cosmic Ray (GCR) spectrum; and energetic protons as-
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2TABLE I: The parameters that describe the simulated
Manned Orbiting Laboratory mission orbit (adapted from
Charles et al.5)
Orbit Parameter Value
Apogee 344.5 km
Perogee 148.20 km
Inclination 96.5◦
Altitude (highest) 344.5 km
Altidude (lowest) 148.2 km
Ascending Node 351.88◦
Argument of Perigee 196.77◦
True Anomaly 152.48◦
Eccent ricity 0.01
Number of Orbits 16.13 per day
Launch July 15, 1972
Landing August 14, 1972
sociated with a Solar Particle Event (SPE). The fluence
(the number of incident particles crossing a given plane)
of GCR particles in interplanetary space fluctuates in-
versely with the solar cycle, with dose-rates ranging be-
tween 50-100 mGy/year at solar maximum and 150-300
mGy/year at solar minimum4,14. Here mGy is the ab-
breviation for milligray, where the Gray is the SI stan-
dard unit for the measurement of ionizing radiation dose
(1 mGy = 0.001Gy)9.The occurrence of SPEs is unpre-
dictable but dose rates as high as 1500 mGy/hour have
been measured15,17. The background dose rate for solar
protons (e.g., the solar wind) varies with the solar cycle
(9-14 years, average 11 years per cycle), but even at so-
lar maximum the dose rate is much less than the GCR
dose rate and therefore it is considered to be of negligible
risk.
One of the most important questions to be answered
for future NASA, commercial, and military spaceflight
missions focuses on the short and long-term health ef-
fects of space radiation on participants. Commercial,
government, and military spaceflight crews could be ex-
posed to SPEs that might induce prodromal effects in-
cluding fatigue, malaise, nausea, and vomiting, and fur-
ther exacerbate biological outcomes from the concur-
rent chronic GCR environment. The indigenous shield-
ing provided by the Earth’s magnetic field attenuates the
major effects of space radiation exposures for current
NASA missions which orbit mostly below it. Addition-
ally, the relatively low (51.6◦) inclination of the Interna-
tional Space Station provides significant protection and
is responsible for this attenuation of radiation exposure in
current missions. The (proposed) MOL flights intended
for a polar orbit would not have had this luxury and would
have been susceptible to high-energy charged particles
penetrating the Earth’s Magnetosphere at such latitudes.
Each charged particle has the ability to damage critical
cellular components when passing through the tissues of
the body. In addition, neutrons produced by interactions
of cosmic rays passing through the spacecraft structure
can be highly penetrating and deliver a significant dose
to critical organ systems. It is reasonable to presume that
future commercial, government, and military spaceflight
missions may have vehicles with similar shielding and
polar orbital profiles, leaving the crew exposed to high
fluences of cosmic radiation and high dose-rate SPEs
that are unpredictable in frequency and intensity. We
sought to model the radiation exposure that would have
occurred during a planned MOL mission in order to un-
derstand the potential short- and long-term health effects
on exposed crewmembers and to provide context for fu-
ture spaceflights of similar duration and orbital parame-
ters.
I. METHODS
Advanced numerical methods and high-performance
computing capabilities allow for an accurate simulation
of multiple environmental factors. These include the or-
bital path as a function of longitude, latitude, and altitude;
the geomagnetic profile and field strength along the or-
bit; fluctuations in the density of space radiation due to
geomagnetic field strength; and variations in solar ac-
tivity. We have derived these parameters using widely-
accepted standard models: the IGRF-12 geomagnetic
field model22, the AE9/AP9 models that describe Earth’s
trapped radiation environment8, the King and CREME96
solar proton models for nominal and contingency solar
proton flux6,12, the ISO 15390 Standard Model for GCR
flux19, and PHITS18 (Particle and Heavy Ion Transport
System) for approximating the dose behind shieldingma-
terial. The details of these models can be found in the
referenced text and will not be discussed in this report.
The mission ground tracks were reproduced with the
sun-synchronous orbit profile shown in Table I resulting
in the approximate trajectory shown in Figure 2. This
high inclination orbit (96.5◦) is commonly referred to as
a polar orbit. This provided the necessary input for the
IGRF-12 model to determine geomagnetic profile and
field strength along the orbit path. This determined the
particle cutoff threshold and attenuation for the trapped
protons, SPE protons, and GCR nuclei that would com-
promise the local radiation field.
Two test cases were performed for typical and worst-
case mission scenarios (hereafter referred to as nominal
and contingency, respectively). The nominal test case
accounted for the radiation spectrum impinging the MOL
vehicle along its orbit over the course of its 30-day mis-
sion. The radiation field included GCR nuclei, trapped
protons and electrons, solar wind nuclei, and one small
size SPE. The small size SPE was added for accuracy
since it was statistically likely that a small- to medium-
sized SPE event would occur over the planned mission
duration. The contingency test case included the radia-
tion field from the nominal test case and added the proton
contribution from the infamous and large SPE that hit the
LEO environment on August 4, 1972, described by the
spectrum,
3i = 96.5 
orbit direction, 
northbound 
orbit direction, 
southbound 
FIG. 2: The MOL mission profile as a function of orbit longitude, latitude and altitude. The high inclination orbit requires
passes directly over the northern and southern polar regions. The inclination, shown on the figure as i, is defined as the angle
between the orbital path and the Earth’s equator. The large arrows highlight the north versus southbound direction of the
ground tracks. Here we can easily see that lower altitudes correspond to the area around Russia and the highest altitudes are
during transversal of the polar regions, minimizing the exposure to cosmic rays and energetic solar protons.
J(> E) = 7.9x109 e(30−E)/26.5 (1)
for protons with energies between 10-200 MeV (mega-
electron volt). The electronvolt is the energy gained by
an electron accelerated through a potential difference
of 1 Volt9. In SI units, the electronvolt is equivalent
to approximately 1.602176 x 10−19 Joules (1 MeV =
1,000,000 eV). Here the fluence J is given in cm−2 and
the energy, E, in MeV12. The resulting radiation fields
for the nominal and contingency test cases were both in-
tegrated over the duration of the MOL mission and then
the vehicle shielding was applied using the Monte Carlo-
based particle transport platform, PHITS, to determine
the intravehicular dose. The integrated proton fluences
for both cases are shown in Figure 3(a).
The August 4, 1972, SPE event is interesting for space
radiation studies because the proton spectrum includes a
large contribution from protons with energies exceeding
100 MeV. A 100 MeV proton has sufficient energy to pen-
etrate typical spacecraft shielding (5-10 g/cm2) and still
have enough remaining energy to reach bone marrow
and blood forming organ (BFO) depths. In fact, this SPE
accounted for approximately 83% of the ≥ 100 MeV pro-
tons measured during solar cycle 20, which lasted from
approximately October 1964 to March 197612. The Au-
gust 1972 event is also relevant because it occurred dur-
ing the period in which MOL missions were projected to
occur. Thus, our consideration of its implications reflects
a reasonably probable event for the MOL program if it
had been implemented. The physiological, behavioral,
and operational results of the MOL program have been
discussed by Jenne11.
The true value of MOL vehicle shielding is currently
not available and the recently declassified and available
program documents do not sufficiently describe the ve-
hicle material and thickness. For this study, we assumed
theMOL vehicle was similar to the Skylab vehicles-which
almost certainly overestimated MOL shielding capacity-
approximated an isotropic (e.g. the same value in all
directions) shielding of 5 g/cm2. For perspective, the
Apollo crew vehicle shielding was 5-10 g/cm2, while the
ISS is approximately 30-50 g/cm2 of shielding mass23.
The bootstrap method was utilized for error analysis to
verify the statistical stability of the results and minimize
systematic biases in the outcomes3. Additionally, some
validation of our results was done by applying our meth-
ods to the orbital profile of the Skylab missions (with its
much lower 50◦ inclination). The recorded dose for the
Skylab 4 mission was 178 mSv (milli-Sievert) for an 83
day mission15. Our model approximation determined a
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FIG. 3: (a) Proton fluences for both the nominal and contingency test cases. The gray shaded box emphasizes the enhancement
of ≥ 100 MeV protons for the case where the August 1972 SPE is included in the dose projections. The ≥ 100 MeV protons can
penetrate typical spacecraft shielding with enough energy to reach bone marrow and BFO depths in tissue. (b) The resulting
dose-equivalent as a function of shielding thickness and areal density. The MOL vehicle had somewhere between 5 g/cm2 to
about 15 g/cm2 (or ≈ 2–6 cm) of shielding, with the lower shielding the most likely configuration. The graph shows that the
addition of the August 1972 SPE increases the mission dose by close to one order of magnitude. Note that there is minimal
difference for areal densities ≥ 30 g/cm2, the approximate average shielding of the massive International Space Station.
mission dose of 152 mSv, or within 15% of the actual
measured dose.
The Sievert is the SI standard of measurement for
equivalent dose (1 mSv = 0.001 Sv). The equivalent
dose is derived from multiplying the ionizing dose (in
Gray) by a weighting factor (wR) that accounts for varia-
tions in observed outcomes of different radiations. Sv =
wR x Gy. The weighting factor is specific to the radiation
species and biologic endpoint and discussed in detail by
Hall and Giaccia9. All results from this study have been
reported in units of millisievert (mSv) for consistency, and
also for comparison with familiar clinical diagnostic and
radiotherapy exposures.
II. RESULTS
The results for both the nominal and contingency test
cases are shown in Figure 3(b) where we have deter-
mined the skin dose-equivalent for the intravehicular ra-
diation field. For the nominal test case, the MOL crew
would have received a skin dose of 113.6 mSv and an
approximate BFO dose of 41.6 mSv. In the contingency
scenario, our results indicate the crew would have re-
ceived an exposure of 1,770 mSv and 451 mSv to the
skin and BFO, respectively.
The recent one-year mission completed by a NASA
astronaut and a Russian cosmonaut occurred during
a similar portion of the solar cycle as the MOL mis-
sions; this provides us with a reasonable comparison
of the nominal mission exposure calculations. For the
one-year mission, the dose for any 30-day period would
be 17 mSv during solar maximum and 25 mSv during
solar minimum4. In comparison, the MOL crewmem-
bers would have received a skin dose approximately 4–5
times higher than any 30-day dose received by the one-
year crew.
III. DISCUSION
Evaluation of how the radiation exposures might have
affected the crew is much more difficult to perform and
there are no clear clinical interpretations for either a mod-
est or an extreme scenario similar to our contingency
test-case. Current medical standards are largely based
on epidemiology studies of human populations exposed
to whole body irradiation at high doses and high dose-
rates limited to scenarios not found during spaceflight
missions. The research challenge posed to radiation re-
searchers is outside of the scope of this study and de-
tailed in numerous other publications. It suffices to say
that research focused on space radiation induced hu-
man health effects, unlike bone health, nutrition, cogni-
tive functions, etc., does not have a human model ex-
posed to the environment for properly evaluating the risk,
let alone clinical mitigation.
It should be noted that the medical spaceflight stan-
dards are derived implicitly for NASA astronauts who
have met a rigorous standard of health. Caution should
be taken when evaluating the nominal and contingency
doses for non-astronaut spaceflight passengers (e.g.
commercial spaceflight tourism). Even so, some clini-
cal outcomes can be anticipated and elucidated in the
context of NASA’s spaceflight health standards for pre-
serving astronaut crew health24.
The contingency scenario mission dose would sur-
pass both the 30-day and the annual limit for BFO estab-
5TABLE II: NASA 30 day, annual, and career exposure lim-
its for astronauts compared with predicted Manned Orbiting
Laboratory nominal and contingency exposures (in mSv)15,24.
Program Exposure Period Skin Eye BFO
NASA 30 Days 1,500 1,000 250
Annual 3,000 2,000 500
Career 6,000 4,000 n/a
MOL 30 Days (nominal) 113.6 n/a 41.6
30 Days (contigency) 1,770 n/a 451
lished by NASA for radiation exposure in LEO (as seen
in Table II). More than 90% of the dose incurred in this
scenario is due to an acute exposure to energetic pro-
tons at an average dose rate of 23 mSv/hr. This is two
orders of magnitude higher than the nominal dose rate
of 156.9 µSv/hr (0.1569 mSv/hr) or the approximate av-
erage nominal dose rate of 29 µSv/hr for the recent one-
year mission. These doses are likely to induce prodromal
symptoms, but not expected to be implicitly life threaten-
ing with prompt instigation of medical countermeasures.
It is important to note that this conclusion is made based
on the robust health requirements of current NASA astro-
nauts and would need to be re-evaluated for individuals
that do not meet those standards.
The prodromal phase of acute radiation syndrome
includes clinical symptoms of nausea, vomiting, and
anorexia, and may manifest within 48 hours following
the SPE exposure. These symptoms may also develop
within a few hours of radiation exposure7; higher SPE
doses can result in increased severity, quicker onset, and
longer duration of the symptoms1. Emesis, fatigue, and
other expected symptoms could seriously impair crew
performance and mission success. Recent research
results from an SPE-like proton distribution on a ferret
model indicated that emesis responses were observed
in doses as low as 400-1,000 mSv20. Prodromal vomit-
ing in humans is expected at doses greater than approx-
imately 750-1000 mSv and is the most likely acute effect
that can impact crew health after exposure to a signifi-
cantly large SPE dose. For comparison, the LD50 (fol-
lowing an acute radiation exposure) for ferrets was deter-
mined by Harding (<2 Gy) and for humans by Hall and
Giaccia (3–4 Gy)9,10. For SPE protons, this would trans-
late to an approximate equivalent dose of 3.5 Sv and
4.5–6 Sv respectively. A minimal increase in fatigue in
the form of depressive or anxious behaviors could mani-
fest after radiation exposure; however, it would be highly
unlikely that the doses modeled here would exacerbate
fatigue or other adverse behaviors over and above base-
line levels26–28.
Although these doses are not by themselves expected
to result in death, it is conceivable that the acute expo-
sure to SPE protons along with other spaceflight stres-
sors such as microgravity could exacerbate radiation-
induce immune suppression, and thus could ultimately
result in severe outcomes if not treated appropriately.
Studies of the synergistic effects of radiation combined
with spaceflight environment stressors (e.g. micrograv-
ity, environment toxicity, emotional stress, etc.) show in-
creased susceptibility to infection, delayed wound heal-
ing and decreased survival13,21,25. Overall suppression
of the immune system may lead to a compromise in crew
health status, so that an SPE-like exposure in combi-
nation with spaceflight environment stressors could en-
hance the risk of pathogenic infection. Outcomes result-
ing from the alterations in levels of immune activation
found during spaceflight, interacting with SPE-like radi-
ation exposure(s) and subsequent immune alterations,
should be evaluated with respect to other physiologic
systems, including bone, muscle, endocrine, neurologic,
respiratory, etc.
There are currently few medical countermeasures
available for the management of the various acute in-
juries that could occur during spaceflight. Burn care,
wound closure and treatment, management of traumatic
injury, antiemetic, and infection control capabilities would
likely be available, but the capability to treat multiple af-
fected crewmembers for extended periods could quickly
outstrip available medical resources. MOL planning
would have permitted the crewmembers to evacuate the
laboratory and return to Earth in short order. Three
well-supported low-latitude recovery zones around the
globe would have accommodated a daylight landing from
the low polar orbit within 12 hours of the decision to
terminate the mission and within six hours if a night-
time splashdown was permitted. This is comparable to
the options for Earth-return currently available to ISS
crewmembers2.
There are still uncertainties in the mechanisms behind
the synergistic lethality observed with radiation injury and
the efficacy of treatments against damage resulting from
radiation-combined injury from other sources (e.g. mi-
crogravity, infection, etc.). Presently, only limited test-
ing has been done on the efficacy of treatment regimens
on traumatic or acute injury when radiation exposure is
a factor, especially charged particle radiation such as
that found in the space environment. In short, the lack
of human exposures to extreme doses and dose-rates
of charged particle radiation limits the ability to provide
sound, clinical-based interpretation of radiation-induced
health effects, particularly when concomitant injury from
other sources is present.
IV. CONCLUSION
We have shown that the unique nature of the low Earth
orbit of the Manned Orbiting Laboratory flights planned,
but not flown, in the 1960’s would have exposed its crews
to a problematical radiation dose. While the nominal
30-day mission’s exposure would have been well within
current NASA limits, the contingency scenario includ-
ing the August 1972 SPE would have exceed NASA’s
630-day limit for skin exposure and would have been
nearly double the limit to BFO. The contingency sce-
nario may have caused transient illness in healthy and
highly-conditioned MOL pilots, but similar exposures to
individuals with less-than-astronaut fitness would proba-
bly cause greater distress than could be accommodated
in future NASA, commercial and military LEO vehicles.
Appropriate attention to mission and vehicle design and
available radiation countermeasures is advisable.
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